News Daily News Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality Yael L. Maxwell December 12, 2024
News Daily News FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy L.A. McKeown November 25, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024